Genistein is capable of modulating hyperglycemia by activating the hepatic IRβ/PI3/AKT signaling pathway, increasing the phosphorylation of hepatic Foxo1/GSK3β and improving glucose metabolism of liver. Here, FOXO1 is linked to Hyperglycemia.